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Dietary supplementation with the antioxidants vitamin E and selenium (Se) has
been shown to be beneficial against the intracellular parasite Trypanosoma cruzi during
experimental Chagas' disease. Supplementation of mice with vitamin E and selenium at
levels well above the recommended daily allowance for these two substances results in
significantly decreased parasitemia levels and increased longevity. However, the
mechanistic role of the antioxidants in this process is not well understood. It is known
that vitamin E and selenium can reduce oxidative stress and improve host immune
responses. In addition, the synthesis of many regulatory cytokines is known to be
influenced by changes in the cellular oxidant/antioxidant balance. The present study was
performed to determine the impact of the antioxidants vitamin E and selenium on the T
helper (Th) 1/Th2 cytokine balance during experimental Chagas' disease. In the first
phase of the study, two groups of female C3HeB/FeJ mice (24 mice each) were
supplemented with vitamin E and selenium for 4-5 weeks and 8-9 weeks, respectively. In
the second phase, 12 mice from each group were infected with a Brazil strain of
Trypanosoma cruzi. In the final phase, levels of interferon gamma (IFN-y and interleukin
10 (IL-10) in serum were measured by antigen-capture enzyme linked immunosorbent
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assay (ELISA). Transcriptional levels of IFN-y and IL-10 message RNA (mRNA) in the
heart and spleen were measured by a ribonuclease protection assay. The results of the
study confirmed the previously observed beneficial effect of antioxidant supplementation
during murine infection with T. cruzi. In addition, supplementation of mice with vitamin
E and selenium was shown to affect IFN-y and IL-10 synthesis at both the serum level
and transcriptional level. Furthermore, IFN-y and IL-10 levels differed in the heart and
spleen of infected mice. The Thl/Th2 cytokine balance was shown to be predominantly
Thl in mice receiving antioxidant supplementation. Vitamin E and selenium apparently
exert a protective effect by enhancing IFN-y levels in mice infected with T. cruzi while
decreasing the levels of IL-10 in non-infected, antioxidant-supplemented mice.
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BACKGROUND
Trypanosoma cruzi and Chagas' disease
Trypanosoma

cruzi, the causative agent of Chagas' disease, is transmitted by

triatomine insects or by blood transfusion. Trypanosoma cruzi is a flagellated eukaroytic
protozoan. The parasite is polymorphic and shows 3 different developmental stages in its
life cycle: trypomastigote, amastigote and epimastigote.
The trypomastigote is the infective stage of T. cruzi and the only form transmitted
between mammalian hosts and the invertebrate vector. It has a slender C-shape and is 12
to 20jim long and 2|xm in width (Wendel and Gonzaga, 1993). The vectors of T. cruzi
are hematophagus bugs of the family Reduviidae (Kissing bugs).

Panstrongylus,

Triatoma and Rhodnius are three genera of this family that are important in the spread of
Chagas' disease to humans.
Within the midgut of the insect, trypomastigotes transform into short epimastigote
stages, which multiply by longitudinal fission. The epimastigote is the replicative form of
the parasite in the invertebrate host. After passing to the posterior intestine, they
differentiate into the metacyclic trypomastigote stage. These infective trypomastigotes
appear in the insect rectum 8 to 10 days after the blood meal (Roberts and Janovy, 1996).
The bugs puncture the skin of the host in order to take a blood meal, and if the infective
trypomastigotes are contained in feces, they gain entry into the host through the bite
wound, scratched skin, or across mucous membranes that are rubbed with contaminated

1

2
fingers. After entry into the body of the mammalian host, trypomastigotes invade various
nucleated cells. The most frequent cells are macrophages, muscle cells, nerve cells and
reticuloendothelial cells of spleen, liver and lymphatics. Once in these cells, the
trypomastigotes transform into the amastigote stage.
Amastigotes are spheroid, approximately 1.5 to 4.0 |im wide, and lack a
flagellum. They are the intracellular replicative forms of T. cruzi in mammalian cells.
After reproducing several times, amastigotes transform back to the trypomastigote stage.
Blood-form trypomastigotes (BFTs) are released from ruptured cells and then infect other
host cells. When circulating trypomastigotes are present in peripheral blood, they can
infect the insect vector during a blood meal.
Symptoms and pathogenesis
There are three clinical stages in Chagas' disease: an acute stage, an
indeterminant stage, and a chronic stage. The acute stage begins with the entrance of
metacyclic trypomastigotes into the host's cells. Local inflammation at the wound site
results in the formation of a small red nodule, known as a chagoma, with accompanying
swelling of regional lymph nodes. Chagoma of the eye (Romana's sign) is seen
frequently (Roberts and Janovy, 1996).
Acute myocarditis of different degrees also may occur. If parasites infect the
nervous system, acute meningoencephalitis can develop and histopathological lesions in
the meninges can be observed. Generally, the younger the patient, the more severe the
clinical manifestations. Fatal diseases frequently occur in patients under two years old
(WHO, 1991). In the acute stage, general malaise occurs along with a variety of possible
clinical manifestation including the following: fever, enlarged liver and spleen,
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generalized edema, swollen lymph nodes, sometimes a generalized exanthematous rash,
anorexia, diarrhea, and vomiting.
The indeterminant stage is clinically asymptomatic and may last several years or
persist indefinitely. In the chronic stage, patients suffer from cardiac, digestive, or
neurological damage 10-20 years after being infected with parasite. The inflammatory
process is most frequently focused in the heart, which results in chronic myocarditis and
varying degrees of cardiac hypertrophy and dilation. If infection occurs within the
esophagus and colon, mega-syndrome may result in the G. I. tract. This chronic
pathology results from the continued presence of the parasite and a massive and
progressive physiological loss of neurons, which are incapable of regeneration.
Patients with Chagasic heart disease develop severe cardiomyopathy leading to
varying degrees of cardiac hypertrophy, dilation, and congestive heart failure that is
caused by the destruction of parasympathetic ganglia, myocardium, and heart conduction
fibers (WHO, 1991).
Host immunity to T. cruzi
Both natural resistance and acquired immunity are involved in the defensive
response of the host following T. cruzi infection. Amphibians and birds are completely
resistant to T. cruzi; the mammalian host cannot destroy infective trypomastigotes and
allows them to remain alive for several weeks until parasite-specific antibodies are
formed. Once the antibodies are formed, trypomastigotes may be killed by the activation
of complement lysis. Cytotoxic T lymphocytes, macrophages, neutrophils, eosinophils
and natural killer cells also have been shown to participate in immunological defense
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during infection. The cell-mediated immune response against T. cruzi has been shown to
be critically important, especially during the acute phase (Roberts & Janovy. 1996).
Interferon-gamma, CD8+ T lymphocytes, macrophages, and tumor necrosis
factor-beta (TNF-P) play important roles in controlling parasite replication. Within
macrophages, nitric oxide synthesis is a major protective mechanism against intracellular
parasitic infection (Green et al., 1991).
During the very early stages of experimental

T. cruzi infection,

immuno-

suppression occurs and contributes to the pathological effects. Production of the cytokine
interleukin-2 (IL-2) and one subunit of the IL-2 receptor are suppressed early in infection,
and the subsequent severe nonspecific immunosuppression that follows is a well-known
hallmark of Chagas' disease. One consequence is that T cells can't be activated by
antigen, mitogen, or anti-CD3 monoclonal antibody. However, levels of many other
cytokines increase dramatically during infection, such as IFN-y and IL-10 (Zhang &
Tarleton, 1996).
CD4+ T lymphocytes are required in mediating host resistance during chronic
Chagas' disease (Brener & Gazzinelli, 1997). Thl cells play a helper/regulatory role in
CD8+ T cell cytotoxicity directed against T. cruzi-infected

cells. In addition, parasite-

specific Thl cells activate macrophages to kill intracellular amastigotes of T. cruzi by a
mechanism exclusively dependent on the induction of nitric oxide synthesis (Rodrigues et
al., 2000).
Compared with cellular responses, antibody production is secondary but appears
to be necessary for control of T. cruzi (Kumar & Tarleton, 1998). Humoral responses
control chronic infections in which immunoglobulin M (IgM) and Immunoglobulin G
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(IgG) play major roles. Both protective and non-protective antibodies can be found in
hosts infected with T. cruzi. Protective antibodies, such as some circulate IgGs, function
in opsonization, complement fixation and lysis of living trypomastigotes.

Autoantibodies have been hypothesized to play a role in the pathology of Chagas'
disease for many years. However, more recent evidence suggests that the continued
presence of T. cruzi in host tissues stimulates a chronic inflammatory response with
infiltration of lymphocytes and macrophages (Tarleton & Zhang, 1999).

Cytokines and Thl/Th2 balance
Cytokines are low molecular weight regulatory proteins or glycoproteins secreted
by leucocytes and various other cells in the body in response to a number of stimuli.
Their production is carefully regulated. They serve as chemical messengers of the
immune system by binding to receptors present on numerous types of target cells. Their
primary function is to regulate the proliferation, differentiation, and effector activity of
immune-system cells. Many types of cells can secrete cytokines, such as Theiper cells, Blymphocytes, NK cells, macrophages, mast cells and other cell types. CD4+ Theiper (Th)
lymphocytes exert most of their helper functions through the action of secreted cytokines.
The differences in cytokine-secretion patterns among Th-cell subsets can determine the
type of immune response made to a particular antigenic challenge. Two CD4+ Th-cell
subpopulations can be discriminated by the cytokine-patterns they secrete. These two
subpopulations are designated as Thl and Th2. Whereas Thl cells are required for the
development of immune control to T. cruzi, Th2 cells contribute to parasite persistence
and increased severity of disease (Tarleton et al., 2000).
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The Thl subset has a cytokine profile consisting of high levels of IL-2, IFN-y,
TNF-(3 and GM-CSF that act primarily in cell-mediated responses. Thl cytokines can
promote macrophage function necessary to destroy internalized parasites. However, Thl
cytokines may also be responsible for the excessive inflammation and tissue injury. In a
Th2-type immune response, there are high levels of IL-10, IL-4, IL-5 and IL-13, which
can function in B-cell activation and in the stimulation of the humoral response while
down-regulating macrophage activation. The Th2 subset is involved in the activation of
eosinophils and participates in the type I hypersensitivity reaction. Thl and Th2
regulatory cytokines stimulate the growth of the subset that produces them and crossregulate the other subset in order to maintain the Thl/Th2 balance. In this way, cytokines
can determine the progression and outcome of many diseases. The increased production
of cytokines derived from the Th2 subpopulation of CD4+ T cells may cause a fatal
outcome in chronic human chagasic disease (Reis et al., 1997).
IFN-y is a defining cytokine of the Thl subset and is produced by Thl cells and
NK cells.

IFN-y can activate macrophages to increase microbicidal activity, it can

increase NK cell activity, and it can up-regulate the level of class II MHC expression and
the secretion of cytokines such as IL-12, which induce Th cells to differentiate into the
Thl subset (Boeham et al., 1997). IFN-y also promotes the production of certain isotypes
of antibody. IFN-y and TNF-a are cytokines that mediate inflammation. Through their
production, Thl cells can impact inflammatory phenomena such as delayed-type
hypersensitivity. Thl cells also produce IL-2 and IFN-y, which promote the
differentiation of fully cytotoxic T cells from CD8+ precursors. This pattern of cytokine
production makes the Thl subset particularly well suited to respond to viral infection and
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infection by other intracellular pathogens. In addition, IFN-y inhibits the expansion of the
Th2 population.
IFN-y is crucial in the determination of resistance or susceptibility during
infection with T. cruzi. In resistant animals, there is strong IL-18 gene expression in vivo,
which results in an enhancement of INF-y production (Meyer et al., 1997). IL-18 is
known to be an IL-12 and IFN-y-inducing cytokine and IFN-y-inducing factor. Nitric
oxide (NO) is derived from macrophages and plays a critical role against different kinds
of pathogens such as bacteria, viruses, fungi, and protozoan parasites. Nitric oxide has
been shown to be a crucial killing effector molecule in resistance to intracellular stages of
T. cruzi (Holscher et al., 1998). IFN-y is necessary for NO production that is mediated by
the inducible nitric oxide synthase (NOS).
IL-10, secreted by Th2 cells, is an anti-inflammatory cytokine which participates
in the cross-regulation of Thl cells and has immunosuppressive functions through the
down-regulation of IFN-y (D'Andrea et al., 1993). IL-10 indirectly inhibits Thl cells by
acting on monocytes, macrophages and other antigen presenting cells. IL-10 downregulates the expression of class II MHC molecule on these antigen-presenting cells,
interfering with their ability to activate the Thl subset. IL-10 also acts on the monocytemacrophage lineage to suppress the production of nitric oxide and other metabolites
involved in the destruction of pathogens. The production of various inflammatory
mediators (IL-11, IL-6, IL-8, GM-CSF, a-CSF and TNF-a) also is inhibited. Two Th2
cytokines, IL-10 and IL-4, down-regulate the secretion of IL-12, which is the critical
cytokine of Thl differentiation. The suppressive effects on macrophages by Th2 subset
cytokines can further diminish the biological consequences of Thl activation. The
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function of T-cell subpopulations in immune regulation during T. cruzi infection is still
not completely understood. However, cytokine control is very important during T. cruzi
infection. Thl cytokines have been shown to play a vital role in the control of parasite
infections. In addition, there is a critical requirement for IL-10 to prevent the
development of potential tissue pathology associated with CD4+ T cells and the
overproduction of IL-12 and IFN-y (Hunter et al., 1997).

During experimentally induced Chagas' disease, cytokines play key roles in the
regulation of both parasite replication and the immune response in infected hosts. A Thl
immune response characterized by IFN-y production and subsequent activation of
macrophages plays a major role in resistance to acute T. cruzi infection. IFN-y is
particularly important in the very early stage of T. cruzi infection in determining disease
outcome. By day 60 or later in infection, the balance of type 1 and type 2 cytokines is
shifted in favor of IL-4 and IL-10 (Talvani et al., 2000). Endogenous IL-10 can downregulate the pro-inflammatory cytokine response, which unchecked can lead to TNFalpha-mediated toxic shock (Holscher et al., 2000). The balance between protective (e.g.,
IFN-y) and exacerbative cytokines (e.g., IL-4 or IL-10) could be responsible for disease
control and progression (Meyer et al., 1998). Although it is not a major determinant of
susceptibility to Y strain T. cruzi infection, endogenous IL-4 along with IL-10, modulates
IFN-y production and resistance (Abrahamsohn et al, 2000). Chronic human Chagas'
disease is associated with increased systemic production of type 2 cytokines in response
to T. cruzi infection and may be involved in the reciprocal down-regulation of IL-2
production (Samudio et al., 1998).
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Neutralization of endogenous IL-10 in vivo increases resistance to infection with
T. cruzi by increasing inflammatory cytokine responses, thus leading to reduced
susceptibility (Dai et al., 1997). However, IL-10 prevents the development of a
pathological immune response, which is correlated with CD4+ T cells and the
overproduction of IFN-y. Interleukin-10-deficient mice died within the third week of
infection with T. cruzi, whereas all control mice survived acute infection (Holscher et al.,
2000). In T. cruzi-infected

IL-10-/- mice TNF-a was shown to be the direct mediator of

mortality due to toxic shock. The dual role of IL-10 is illustrated by the observation that a
reduced parasitemia but caused increased mortality occurs in IL-10 deficient mice
infected with T. cruzi (Abrahamsohn & Coffman, 1996).
Antioxidant nutrient and Immune system
Single oxygen radicals, free radicals, and other reactive metabolites of oxygen are
the by-products of metabolism. One family of molecules derived from the partial
reduction of molecular oxygen is the reactive oxygen intermediates (ROI) that are
released by the host from stimulated granulocytes and macrophages. Because of their
free radical nature (i.e., the presence of an unpaired electron) and loss of spine restriction,
ROI can react avidly with organic molecules and their active oxygen intermediates
causing damage to DNA, proteins, and polyunsaturated membrane phospholipids in
living organisms by oxidation.
The immune system can produce and use free radicals and reactive oxygen
molecules, especially during the early stages of infection (Deshpande et at, 1996). The
production of reactive oxygen intermediates is beneficial in the destruction of pathogens
such as bacteria, viruses, fungi, and protozoan parasites. However, overproduction of free
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radicals and reactive oxygen molecules can injure the immune cells themselves, as well
as neighboring cells and tissues (Truyens et al., 1999).
Under normal conditions, free radicals are removed as soon as they are formed.
For example, hydrogen peroxide is metabolized by the antioxidant enzyme, glutathione
peroxidase (Diplock, 1991). Superoxide dismutase (SOD) can remove the superoxide
anion radical in the mitochondrial compartment. The activity of these and other
antioxidant enzymes is critical for preventing the accumulation of free radicals. SOD is
copper and zinc dependent; therefore, its function is dependent on the presence of
nutritional antioxidant minerals, such as copper, zinc, manganese, and selenium. Vitamin
E, vitamin C, and (3-carotene exert their antioxidant function by the formation of preoxidant substances instead of highly reactive free radicals. Pre-oxidants are much less
reactive and have lower energy levels than the free radicals that they quench (Deshpande
et al., 1996). Besides the capacity to scavenge free radicals, these antioxidant
mechanisms are also important in disease prevention. For example, vitamin E plays an
important role in the regulation of membrane fluidity and stabilization, 5-lipooxygenase
activity, and protein kinase C activities (Blumberg, 1995).
Many studies also have shown that antioxidants can reduce the risk of some
cancers, cardiovascular disease, infectious diseases, and damage due to pro-oxidant
environmental pollutants such as smog and cigarette smoke. In addition, antioxidants can
provide protection against inflammation and autoimmune disease (Deshpande et al.,
1996). The antioxidant defense mechanism will be negatively affected when there is a
deficiency in any of these nutrients.
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It has been demonstrated that there is an increased production of reactive oxygen
species by cells from mice acutely infected with T. cruzi (Cardoni et al, 1990). In
addition, increase ROI production parallels the parasite burden during the acute phase of
Chagas' disease.

Many experiments have shown that clinically relevant immune functions can be
enhanced safely and effectively by supplementation with vitamin C, vitamin E, or
(3-carotene during conditions of increased oxidative stress (De la Fuente et al., 1998)
Previous studies in our laboratory have provided evidence for a beneficial effect of
elevated levels of vitamin E and selenium in the diet of mice infected with T. cruzi. The
effects observed included reduced parasitemias, increased survival rates, and reduced
weight loss during infection (Bennett, 1995; Hou, 1997).

Vitamin E
Vitamin E, tocopherol, has been known as an antioxidant and immunostimulator
for many years. As a lipid-soluble antioxidant, vitamin E is essential for the integrity and
optimal functioning of all mammalian cells. This antioxidant property is the primary
biological function of vitamin E. Vitamin E can stabilize biological membranes by
protecting polyunsaturated fatty acids and other components of cell and organelle
membranes from oxidation by reactive oxygen intermediates (Tappel 1972; Dutta-Roy et
al., 1994). Cellular structures also can survive the damage of oxygen free radicals and
reactive products of lipid peroxidation in the presence of vitamin E (Deshpande et al,
1996).
Vitamin E also has beneficial effects on immune function. It can protect the
immune system from the harmful effects of free radical reactions and high levels of
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vitamin E can have a stimulatory effect on the immune system. High doses of vitamin E
in animals can stimulate cell-mediated immune function and increase humoral antibody
production. The beneficial functions of vitamin E include the enhancement of T-cell
mitogenesis, IL-2 production, T helper cell activity, B-cell mitogenesis, NK activity,
macrophage phagocytosis, antibody titer, and DTH responses (Moriguchi and Muraga,
2000)
Deficiencies in vitamin E lead to a decline or suppression of the immune
response. In addition, vitamin E deficiencies negatively affect both the maturation of
specific lymphocyte subpopulations as well as the functional and proliferative capabilities
of the peripheral lymphocytes (Chang et al., 1994).
Vitamin E is rich in dark green vegetables and vegetable oils, but generally poor
in animal products (Budowski and Sklan, 1989). The most widely available form of
vitamin E in food is a-tocopherol which demonstrates the highest biological activity.
International units (IU) are usually used to express the amount of vitamin E present. Two
mg of a-tocopherol equal to 3 IU (Dutta-roy, et al., 1994). The recommended dietary
allowance (RDA) of vitamin E for men and women is 15 IU and 12 IU/person /day,
respectively (Meydani, 1995).
Selenium
Selenium is an antioxidant mineral and can be found in a variety of food sources,
such as fish, meat, butter, cabbage, celery, radishes, garlic, and whole grains. Selenium is
important to all mammalian cells because it is an essential component of several
enzymes, which function in redox reactions. Spallholz (1994) reported that selenium is
essential for the integrity of glutathione peroxidase (GSH-PX), an antioxidant enzyme
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that can reduce intracellular peroxides and functions as a cellular protector against
oxidative damage. Selenoprotein P is another major participant in selenium metabolism
(Burk and Hill, 1994).
Selenium also is required for normal growth and development and functions as an
antioxidant at the cellular level. Selenium has been shown to have anticarcinogenic
function in vivo and in vitro and can decrease the risk of some cancers such as ovarian
cancer (Stenson, 1996). Dietary intake of selenium affects immune function. Selenium
supplementation increases the production of some classes of antibody, such as IgM and
IgG (Spallholz et al, 1973) and significantly increases splenic lymphocyte activity,
cytotoxic T lymphocyte-mediated tumor cytotoxity, and lymphokine-activated killer
cells. Macrophage and natural killer (NK) cell activity also has been shown to be
enhanced during selenium supplementation compared to baseline values (KiremidjianSchumacher et al., 1994). Selenium also can make up for age-related deficiencies in
lymphocyte proliferation and differentiation into cytotoxic effecter cells. The molecular
mechanisms involved in the impact of selenium on immune cell function may not be
related to the function of selenium as an antioxidant or to gene activation (KiremidjianSchumacher and Roy, 1998).
Both deficiency and excess of selenium have the potential to be damaging to the
immune system and other animal systems (WHO, 1987). Long-term selenium deficiency
has been known to contribute to two diseases: (1) Keshan disease, which is a
cardiomyopathy of children and young adults; (2) Kachin Bech diseases, which are
osteoarthropathies of young people (WHO, 1987). Selenium supplementation can prevent
both of these diseases.
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The impact of selenium supplementation during bacterial, yeast, parasitic, and
viral infection is somewhat variable. In some models of infectious disease selenium
reportedly increases resistance, while in other systems it may actually impair the host
response (Boyne et al., 1984).
Combined Effect of Vitamin E and Selenium
Both vitamin E and Se function as antioxidants; either of them can impact the
immune system and can provide protection against some diseases in humans and other
animals. Vitamin E and selenium show a positive synergistic effect on the immune
system when supplemented in quantities in excess of recommended levels (Scheffy and
Schultz, 1979). Combined supplementation of Se and vitamin E result in enhanced
macrophage function (Wise and Tomasso, 1993) and also enhanced antibody production,
cell proliferation, cytokine production, prostaglandin metabolism, and neutrophil function
(Desphande et al, 1996). Vitamin E and selenium also show a synergistic effect in
depressing lipid peroxide formation. The combination of 400IU/kg vitamin E and 8ppm
selenium provided the best overall protective effect in a murine model of experimental
Chagas' disease (Hou, 1997). Douillet et al. (1996) showed that Vitamin E and Se
exerted a synergistic beneficial effect in protecting kidney damage in diabetic rats. A
significant correction of renal hyperfiltration and a diminution of the number and severity
of glomerular lesions was observed in rats supplemented with both antioxidants.
Selenium and vitamin E showed overlapping and synergistic functions in an
experiment in which C57B1/6J mice were fed different levels of these antioxidants
during infection with coxsackievirus B3 (CVB3) (Williams et al., 1994). However, the
two antioxidants have different functions and often can't compensate for each other.
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Vitamin E protects lipid membranes against oxidative stress in two ways: by catalyzing
the destruction of hydrogen peroxide or by catalyzing the decomposition of lipid
hydroperoxides. Selenium acts as a component of glutathione peroxidase (GPX) in the
cytoplasm and protects - S H groups in membrane proteins against oxidation (Zhu et al.,
1992). Generally speaking, Se can prevent free radical production effectively, whereas
vitamin E plays a role in preventing lipid peroxidation.

INTRODUCTION
The protozoan parasite Trypanosoma cruzi (T. cruzi), infects an estimated 18- 20
million people throughout South and Central America and frequently results in a chronic
heart or digestive tract pathology known as Chagas' disease. In endemic areas, Chagas'
disease remains the leading cause of heart disease and sudden death in young adults
(WHO, 1991). Even though Chagas' disease and the etiologic agent, T. cruzi, have been
well studied, there is currently no vaccine or effective treatment to control this infection.
In general, supplementation with antioxidants such as vitamin E and selenium (Se) has
been associated with an enhancement of the immune response and reportedly increases
resistance to a variety of pathogenic infections and tumors in animal models and in
humans (Wang et al., 1994; Meydani, 1995; Morrissey and Sheehy, 1999).

Most

recently, Han et al. (2000) demonstrated that vitamin E supplementation provides benefit
in a murine model of influenza infection. Mice supplemented with vitamin E showed
lower viral titers, and decreased weight loss following influenza infection. Likewise,
previous studies in our laboratory have shown that supplementation of mice with Se
(Davis et al., 1998) or vitamin E and Se (Hou, 1997) provides benefit during infection
with the intracellular parasite, Trypanosoma

cruzi.

Dietary supplementation with

vitamin E and Se in mice infected with T. cruzi resulted in increased longevity, decreased
parasitemias, and reduced weight loss during infection.
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Lymphocytes known as T helper (Th) cells (or CD 4+ T cells) are known to play
an important role in the regulation and stimulation of immune responses. There are two
currently recognized subsets of Th cells; type I (Thl) and type II (Th2).

Thl cells

produce the cytokines interleukin-2 (IL-2) and interferon-y (IFN-y) and promote cellular
defense mechanisms. In contrast, Th2 cells produce the cytokines IL-4, 5, 6, 9, 10, and
13, which mediate humoral responses including allergic inflammation and asthma. The
balance between Thl and Th2 cytokines influences the consequence of infection by
directing the immunological defense toward cell-mediated or antibody-mediated
responses.

Furthermore, there is reciprocal inhibition, in that Thl-type cytokines inhibit

the production of Th2-type cytokines and vice versa.
The primary goal of this study was to investigate the impact of antioxidant
supplementation on the cytokine response during T. cruzi infection. Cytokine profiles
(especially IFN-y and IL-10) within the hearts, spleen, and sera of T. cruzi-infected mice
were determined. Cytokine production was analyzed at the protein level by antigen
capture enzyme-linked immunosorbent assay (ELISA) of mouse sera and culture
supernatants from cultured murine spleen cells. Cytokine profiles within the heart and
spleen were analyzed at the mRNA level using a multi-probe ribonuclease protection
assay (RPA). The results of the study indicate that the antioxidants vitamin E and Se can
increase IFN-y levels and decrease IL-10 level in serum during infection with T. cruzi,
therefore, shifting the T-helper type response toward a Thl cell-mediated response. A
Thl-type response also was observed at the transcriptional level in the hearts of mice
supplemented with vitamin E and selenium.

MATERIALS AND METHODS
Mice and diets
Female syngeneic mice, strain C3HeB/FeJ (Jackson Laboratory, Bar Harbor, ME)
were used in this study. Beginning at 5-6 weeks of age, mice were randomly separated
into 4 cages of 6 mice each and were maintained at room temperature (26°C). Mice were
immediately placed on one of the diets described below. Three cages of mice were given
a specially formulated chow containing 400 IU/kg of vitamin E (Purina Mills, Richmond,
IN). Distilled water-containing 8ppm sodium selenate was provided as drinking water.
Mice in the remaining three cages were fed a common Purina rodent chow, #5001, which
contained the recommended daily allowance of 0.2ppm Se and 40 IU/Kg vitamins E.
Distilled H 2 0 was provided as drinking water.
Two separate experiments were performed in which mice were treated for
differing lengths of time prior to infection with T. cruzi. Food and water were provided
ad libitum in both experiments.
In experiment #1. the groups were as follows (8-9 weeks of antioxidant treatment prior to
infection):
Group A, 400IU/kg vitamin E plus 8 p.p.m. sodium selenate; assayed 35 days postinfection.
Group B. 400IU/kg vitamin E plus 8 p.p.m. sodium selenate; not infected.
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Group C, (control) Standard Purina Rodent Chow, #5001, plus diF^O. Assayed 35 days
post-infection.
Group D, (control) common Purina Rodent Chow, # 5001, plus diHbO, not infected.
In experiment #2, the groups used were as follows (4-5 weeks of antioxidant treatment
prior to infection):
Group A, 400IU/kg vitamin E plus 8 p.p.m. sodium selenate; assay 37 days postinfection.
Group B, 400IU/kg vitamin E plus 8 p.p.m. sodium selenate; not infected.
Group C. (control) Standard Purina Rodent Chow, #5001, plus diE^O; assay 37 days
post-infection.
Group D, (control) common Purina Rodent Chow, # 5001, plus diF^O, not infected.
All mice were maintained and used in accordance with NIH and local IACUC guidelines.
Parasites
A Brazil strain of Trypanosoma cruzi, which is maintained in the laboratory as a
stock infection in C3HeB/FeJ mice, was used for all experiments in this study. An
infection inoculum of lxlO 3 BFTs in 0.2 ml of Dulbecco's Phosphate Buffered Saline
(DPBS, Sigma Chemical Co., St. Louis, Missouri) was administered intraperitoneally
(I.P.) to each mouse.
Parasitemia
Parasitemia levels were monitored in all infected mice at 3 - 4 days intervals
starting at day 13 post-infection and continuing throughout the course of infection until
mice were euthanized. Blood was obtained from each mouse by clipping the tip of the tail
and squeezing the tail until a uniform round drop of blood was expelled. A 5(il sample of
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blood was obtained from the tail of each mouse and was diluted in 95 |il DPBS (making a
1/20 dilution). A well-mixed sample was counted using a hemacytometer (Fisher
Scientific, Pittsburgh, Pennsylvania). Mice also were monitored daily to determine levels
of mortality and morbidity.
Preparation of Serum
Mice were anesthetized in a j a r containing ether-soaked cotton. A lcc syringe
attached a 26 gauge needle was used to perform a cardiac puncture on the mouse drawing
blood into the syringe. Blood was expelled into a small micro-centrifuge tube and was
allowed to clot at RT for 1 hour and at 4°C overnight. The tube was centrifuged at a
setting of 800 x g for 10 minutes. The supernatants were collected and stored at - 8 0 °C
until use.
Preparation of Spleen Cells
The following procedures were performed under sterile conditions. Following the
removal of blood by cardiac puncture, mice were killed by cervical dislocation. The
abdomen of each mouse was doused with 70% ethanol. A cut was made through the loose
skin in the inguinal region, and the skin was pulled back until the peritoneum was widely
exposed. The loose hair was removed by flooding the peritoneal membrane with 70%
ethanol. The peritoneal membrane was lifted over the spleen with forceps and a large Ushaped cut was made around the spleen. The peritoneum was folded back, and the spleen
was lifted out with forceps. Connective tissue was separated from the spleen with
scissors. The spleen was placed into a small petri dish containing RPMI-1640 medium.
Spleen cells were released from the capsule by squeezing with large forceps. Once the
spleen cells were dislodged, cells were drawn up into a 5cc syringe with a 22-gauge

21
needle and cells were expelled slowly into a 15cc tube through a 26-gauge needle in
order to obtain a single-cell suspension. Erythrocytes were then lysed by hypotonic shock
and cell counts were performed using a hemacytometer. Total spleen cells (4x10 6) were
cultured in 1ml RPMI complete medium (RPMI 1640 medium plus 10% newborn calf
serum, 25mM N-2 -hydroxyethylpiperazin-N'-2-ethanesulfonic acid (HEPES), 5 X 10"5
M-2-mercaptoethanol, lOOu/ml penicillin G, lOOmM streptomycin, ImM glutamine, and
ImM pyruvate. Concanavalin A (ConA: 5ug/ml) was added to some of the spleen cell
cultures to stimulate these cells to produce more cytokines. Culture supernatants were
recovered at 48h and stored at -80°C until enzyme-linked immune sorbant assay (ELISA)
could be performed.
Cytokine ELISA
For enzyme-linked immunosorbent assays (ELISA), 96-microwell plates were
coated with capture antibodies (anti-mouse IL-10 or anti-mouse IFN-y) and incubated
over night. The incubation temperature for the IL-10 ELISA was 37°C. Incubations for
the IFN-y assay were performed at RT. The plates were blocked for 1 hour with 1%
bovine serum albumin (BSA) in blocking buffer. For the IFN-y assay, 5% sucrose in
DPBS with 0.05% NaN 3 was used as a blocking buffer. For the IL-10 assay, 0.25%
Tween 20 in DPBS [Dulbecco's phosphate buffered saline] was used as a blocking
buffer. Serial dilutions of purified recombinant IFN-y and IL-10 were used to generate
standard curves and were incubated in parallel with serum samples and spleen cell culture
supernatants for 2 hours. For the IL-10 assay, samples were first diluted 1:2 in sample
diluent [PBS with 1% BSA 0.25% Tween 20 and 25% heat inactivated bovine calf
serum], Biotinylated anti-mouse IL-10 / IFN-y antibodies were incubated 1 hr or 2 hrs,
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respectively. The plates were washed at 3 times with PBS-0.1% Tween 20. The substrate,
3,3', 5,5' tetramethylbenzidine (TMB; Sigma Chemical Co.), was added to each well and
incubated at RT for - 3 0 min. An enzymatic color reaction was obtained. The optical
densities were measured at a wavelength of 450nm with a microplate reader (BioRad).
Duplicate readings for each standard and sample were averaged, and data were analyzed
according to the protocol described by the manufacturer of the DuoSet ELISA
Development System (R&D Systems, Inc., MN.).
RNA Isolation
Mice were anesthetized by ether inhalation and blood was drawn for serological
analysis by cardiac puncture as described above. Immediately following cervical
dislocation, hearts and spleens were aseptically removed from each mouse, placed into
sterile cryovials, and flash frozen in liquid nitrogen. The cryovials containing frozen
spleen and heart tissue of both infected and control mice were stored at -80°C. Total
RNA was isolated from the heart and spleen cells of each mouse using TRIzol Reagent
(Life Technologies GIBCOBRL, Gaithersburg, MD) according to the protocol suggested
by the manufacturer. Sample tissue was homogenized in TRIzol-Reagent using a glass
homogenizer with a Teflon-pestle. Phenol-chloroform was used for phase separation and
samples were spun in a centrifuge at 12,000x g for 15 minutes at 2 to 8°C. The upper
aqueous phase was collected from each sample and precipitated with 100% isopropyl
alcohol (0.5 ml of isopropyl alcohol per 1 ml of TRIZOL Reagent used for the initial
homogenization). Then, samples were mixed by vortexing and were centrifuged no more
than 7,500x g for 5 minutes at 2 to 8 °C. The resulting RNA samples were re-dissolved in
RNase-free water and were stored at - 7 0 °C until use. RNA yield was quantified by
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spectrophotometry, and RNA purity was confirmed by agarose gel electrophoresis.
Following isolation, RNA samples were diluted in diethylpyrocarbonate-treated (DEPC)
treated distilled water and stored frozen at -80°C until use.
Ribonuclease Protection Assay of Cytokine Gene Transcripts
A Ribonuclease Protection Assay (RPA) was performed on RNA samples isolated
from mouse hearts and spleens using the RiboQuant: Multi-probe RNase Protection
Assay (RPA) System (BD Pharmingen) according to the manufacturer's protocol. The
mCK-1 Mouse Cytokine Multi-Probe Template Set (Cat. #4500IP, BD Pharmingen) was
used in conjunction with the RiboQuant kit for analysis of Thl and Th2 immunoregulatory cytokines. This template set contains DNA templates which were used for the
T7 RNA polymerase-directed synthesis of high-specific activity
[a- P]- labeled
antisense RNA probes that were hybridized with target mouse mRNAs encoding IL-4, L5, IL-10, L-13, IL-15, IL-9, IL-2, IL-6 and IFN-y, as well as two house keeping gene
products: L32 [ribosomal protein L32] and GAPDH [glyceraldehyde-3-phosphate
dehydrogenase]. Details of the probe synthesis are described below. Following
hybridization and ribonuclease treatment, samples were electrophoresed on a denaturing
5% acrylamide sequencing gel. Diluted, unprotected radiolabeled probes were used as
size markers. After electrophoresis, gels were dried under vacuum for 1 hour at 80°C. A
sheet of Kodak X-AR film was placed over the dried gel and the entire assembly was
placed into a cassette with an intensifying screen. Films were exposed at -80°C for 24-48
hours. Films were put in development solution for 30 seconds, fix solution 45 seconds
(keep shaking), and H 2 0 for rinsing 15 minutes. A standard curve was established using
markers (undigested probes) and nucleotide lengths of experimental bands were
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estimated. Autoradiographic band intensities were determined following scanning using
Adobe Photoshop in conjunction with Kodak Digital Science™ computer software.
Probe synthesis
A mCK-1 RPA Template set was used to synthesize probes that were labeled by
[a- 3 2 P] UTP (Amersham). RNasin, a GACU pool, DTT, 5X transcription buffer, the
mCK-1 RPA Template Set, [a-32P] UTP, and T7 RNA polymerase were placed in order
into 1.5 ml microcentrifuge tubes. The samples were mixed well, subjected to a quick
spin in a micro-centrifuge, and then incubated at 37°C for 1 hour. DNase was added to
terminate the reaction, and samples were incubated at 37°C for 30 min. Twenty-six jil
20mM EDTA, 25^1 Tris-saturated phenol [pH8.0], 25^1 chloroform: isoamyl alcohol
(50:1) and 2jll1 yeast tRNA (PharMingen) were then added, and the tube was mixed by
vortexing for 5 min at room temperature. The upper aqueous phase was transferred to a
new 1.5ml micro-centrifuge tube and 50 ja.1 chloroform: isoamyl alcohol (50:1) was
added. The tubes were mixed by vortexing and subjected to a quick spin in a microcentrifuge at room temp. The upper aqueous phase was transferred to a new 1,5ml microcentrifuge tube. Fifty | x l 4 M ammonium acetate and 250 |0.1 ice-cold 100% ethanol were
added and the tubes were inverted, mixed, and incubated for 30 min at -70°C. Then the
tubes were spun in a micro-centrifuge no more than 12,000x g for 15min at 4°C. The
supernatant was removed, and 100 |0,1 ice-cold 90% ethanol was added to the pellet. After
a five minute spin no more than 7,500 x g in a micro-centrifuge at 4°C, all of the
supernatants were carefully removed and the pellet were air-dried for 5 to 10 min. Fifty
of hybridization buffer [80% deionixed formamide + 100 mM sodium citrate pH 6.4 +
300 mM sodium acetate pH 6.4 + l m M EDTA] was added and the pellets were
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solubilized by gently vortexing for 20 sec. One jul sample duplicates were quantitated in
the scintillation counter. A yield of ~3x 105 to ~3x 106 Cherenkov counts/ |xl was
expected. The mRNAs were stored at -20°C. The probes labeled with [cc-32P] UTP were
used for two successive overnight hybridizations.
RNA Preparation & Hybridization
Twenty |xl of target RNase (including a yeast tRNA as a background control and
PharMingen control RNA) were placed into separate 1.5 ml micro-centrifuge tubes.
Samples were dried completely (~1 hour) in a vacuum evaporator centrifuge (no heat).
Eight (0,1 of hybridization buffer was added to each sample and the RNA was solubilized
by gentle vortexing for 3-4 min followed by a quick spin in a micro-centrifuge. Probes
were diluted to 2.9x10 5 Cherenkov counts !\x\ and 2\x\ of diluted probe was added to each
tube and quick spun in the microfuge. The oil added samples were placed into a heat
block pre-warmed to 90°C. The temperature control knob was immediately turned to
56°C (allowing the temperature to ramp down slowly) and tubes were incubated for 1216 hr. The heat block was set to 37°C for 15min prior to the RNase treatments.
RNase Treatments
RNA samples were removed from the heat block and lOO^il of the RNase cocktail
[2.5ml RNase buffer plus 6|il RNase A + T1 mix per 20 samples] was pipeted underneath
the oil (as a bubble) into the aqueous layer. Samples were spun in the micro-centrifuge
for 10 sec and then incubated for 45 min at 30°C. The RNase digests were carefully
extracted from underneath the oil and transferred to new micro-centrifuge tubes
containing 18^1 mixed proteinase K cocktail solution [390(il Proteinase K buffer + 30(il
Proteinase K + 30^,1 yeast tRNA per 20 samples]. The samples were then quickly
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vortexed, spun in the microfuge, and incubated for 15 min at 37°C. Sixty-five |ll Trissaturated phenol and 65|J,1 chloroform: isoamyl alcohol (50:1) were added to the tubes.
The resulting suspension was then vortexed into an emulsion and spun in a microcentrifuge no more than 12,000 x g for 5 min at RT. The upper aqueous phase was
carefully extracted and transferred to a new tube. Ice-cold 100% ethanol and 120(J,1 4 Mammonium acetate were added and tubes were inverted to mix the sample. Following 30
min incubation at -70°C, samples were spun in the micro-centrifuge no more than 12,000
for 15 min at 4°C. The supernatant was carefully removed and the pellet was air dried
completely. A 5 (il aliquot of IX loading buffer [95% formamide + 0.025% xylene
cyanol + 0.025% bromophenol blue + 18 mM EDTA +0.025% SDS] was added, and the
tubes were vortexed for 2-3 min. Following a quick spin in the micro-centrifuge, the
samples were heated for 3 min at 90°C and placed immediately into an ice bath.
Gel Resolution of Protected Probes
A set of gel plates (>40 cm in length) was thoroughly cleaned with water followed by
ethanol. The short plate was siliconized and cleaned again. The gel mold was assembled
using 0.4 mm spacers. A 5% acrylamide solution [74.5 ml acrylamide solution of a final
19:1 acrylamide/bis: 8.85 ml of 40% acrylamide + 9.31 ml of 2% bis acrylamide + 7.45
ml of lOx TBE + 35.82 g of Urea + QS to 74.5 ml with d H 2 0 + 450 jj.1 10% ammonium
persulfate + 60 |il TEMED] was prepared and poured immediately into the gel mold [10
x TBE: 108g Tris Base+ 55g Boric Acid + 40ml 0.5M EDTA, pH 8.0 QS to 1 liter
dF^O], Combs were added and the gel was allowed to polymerize for ~1 hour. The
combs were removed and the wells were flushed thoroughly with 0.5x TBE [1 x TBE:
89mM Tris Base + 89mM Boric Acid + 2mM EDTA], Gels were pre run at 40 watts
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constant power for - 4 5 min, with 0.5 x TBE as the running buffer. Gel temperature was
held constant at 50°C. The wells were flushed again with 0.5x TBE and samples were
loaded. Diluted probes (1000-2000 Cherenkov /lane) were used as size markers. The gel
was run at 50 watts constant power until the leading edge of the bromophenol blue (BPB)
reached a distance of 30cm. The gel mold was disassembled, the short plate was
removed, and the gel was adsorbed to filter paper. The gel was covered with Saran wrap
and layered between two additional pieces of filter paper. The entire assembly was placed
in the gel dryer under vacuum for ~1 hr at 80°C. The dried gel was placed on a sheet of
X-ray film [Kodak X-AR] in a cassette with an intensifying screen and was developed at
-70°C for 24 to 48 hr. With the undigested probes as markers, a standard curve of
migration distance versus log nucleotide length was plotted on semi-log graph paper.
This curve was used to establish the identity of "RNase-protected" bands in the
experimental samples. After scanning the film Adobe Photoshop was used with the
Kodak Digital Science ™ ID to quantify band intensities.
Statistical Evaluation

Data were analyzed using SYSTAT 1999. ANOVA (Analysis of Variance) was
used to test the effect of diet on mice infected with T. cruzi. Dependent variables in the
ANOVA include the concentration of cytokines, the numbers of parasites. Weight of total
RNA and the intensity of RNA band were given as the mean values per group of mice.

RESULTS

Effect of vitamin E + Se supplementation on parasitemia
Mean parasitemia levels for each treatment group in experiment 1 are shown in
Figure 1. The mean parasitemia levels for mice in the vitamin E + Se treated group
(group A) were lower (p< 0.05) than the parasitemia levels of mice maintained on diets
lacking in vitamin E and Se (group C) throughout the course of infection.
Effect of vitamin E + Se supplementation on IFN-y levels
The mean IFN-y concentrations in serum obtained from mice in each group are
shown in Figure 2. Vitamin E + Se-treated mice infected with T. cruzi (group A) showed
higher IFN-y levels in serum than vitamin E + Se deficient T. cruzi infected mice (group
C).

Both older mice in experiment 1 and younger mice in experiment 2 showed

statistically significant differences (Fl=6.71, dfl=10, pl=0.027; F2=6.608, df2=10,
p2=0.028). Interferon gamma levels were not significantly different between the two
groups of non-infected mice (groups B and D) in either experiment.
Mean EFN-y concentrations in Con-A-stimulated spleen cell cultures obtained
from mice in each group are shown in Figure 3. Because levels of IFN-y in spleen cell
cultures were very low and standard deviations were large, no statistically significant
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differences were observed between the two groups of T. cruzi-infected

mice in either

experiment 1 or experiment 2.
Effect of vitamin E +Se supplementation on IL-10 levels
Mean IL-10 concentrations in sera obtained from mice in each group are shown in
Figure 4. Vitamin E and Se-treated but non-infected mice (group B) showed lower IL-10
levels as compared to antioxidant-deficient control mice (group D). This difference was
statistically significant in both experiment 1 and in experiment 2 ( F l = 6.032, d f l = 10,
p l = 0.034; F2=12.61, df2=10, p2=0.005). However, T. cruzi-infected

mice showed no

statistically significant differences in serum IL-10 levels, regardless of diet.
IL-10 levels in ConA-stimulated spleen cell cultures are shown in Figure 5. Only
low levels of IL-10 were detected in spleen cell cultures and standard deviations were
very large. Only mice in group A in experiment 1 (vitamin E + Se and T. crwzi-infected)
showed significantly higher levels of IL-10 as compared with T. cruzi-infected mice from
group C (diet deficient in Vitamin E and Se; F=6.187, df=10, p=0.032). There were no
statistically significant differences in IL-10 levels between other groups of mice.
Effect of vitamin E+ Se supplementation on total RNA production
Mean values for total RNA isolated per spleen and heart tissue are shown in
Figure 6. Although there were no statistically significant differences based upon levels of
antioxidant supplementation, mice maintained on elevated levels of vitamin E + Se
showed an obvious trend toward lower total RNA levels in both spleen and heart tissue.
There were, however, statistically significant differences observed in total RNA levels
between T. cruzi-infected and non-infected groups of mice in both spleen and heart tissue
(spleen: F=44.617, df=4, p=0; heart: F=6.534,df=4; p=0.029). During infection with T.
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cruzi, splenomegaly is very common in the mammalian host; infections represent a strong
antigenic stimulation to the host. The total mass of the organs and the presence of
infection affected the RNA production.
Effect of diet on cytokine mRNA production in T. crazi-infected C3HeB/FeJ mice
According to the estimated intensity of cytokine mRNA bands which were
normalized by the intensity of a house-keeping gene, expression of the following
cytokines were increased in T. cruzi-infected mice: IFN-y, IL-10, IL-9 and IL-15 in both
spleen and heart; IL-6 in heart; IL-4 in spleen (group B versus D in Table la+lb).
Antioxidant-treated mice showed an increase in the expression of the following
cytokines as compared with control, non-supplemented mice: IFN-y in heart, IL-10 in
spleen, IL-15 in heart, IL-6 in heart and IL-9 in both organs (group C versus D in Tables
la + lb). Antioxidant supplementation resulted in a decrease in the expression of the
following cytokines: IFN-y in spleen, IL-10 in heart, and IL-15 in spleen. IL-5, IL-13,
IL-12 levels in the heart and IL-6 levels in the spleen showed no change with response to
infection or antioxidant supplementation.
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Figure 1. Effect of vitamin E and Se supplementation on parasitemia in T. cruziinfected mice. Points represent the mean number of blood-form trypomastigotes per
milliliter of blood (6 mice per group; standard deviations are not indicated to preserve the
clarity of the figure). "+/+"= Group A: vitamin E & Se (+), T. cruzi infection (+). "-/+"
= Group C: vitamin E & Se (-), T. cruzi infection (+).
experiment 1 and the number 2 represents experiment 2.

The number 1 represents

Parasitemia

days
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Figure 2. Effect of vitamin E and Se supplementation on IFN-gamma levels in the
serum of T. cr«z/-infected mice. The concentration of IFN-y present in the serum of
mice in each group was measured on day 35 (experiment 1) and day 37 (experiment 2)
post-infection, respectively. Data are presented as mean concentration plus standard
deviation. Mice in experiment lwere treated with vitamin E & Se for 72 days and were
15-16 weeks old when infected with T. cruzv, Mice in experiment 2 were treated with
vitamin E and Se for 30 days and were 8-10 weeks old when infected with T. cruzi.
"+/+" = Group A: vitamin E & Se (+), T. cruzi infection (+). "+/-"= Group B: vitamin E
& Se (+), T. cruzi infection (-). "-/+"= Group C: vitamin E & Se (-), T. cruzi infection
(+). "-/-"= Group D: vitamin E & Se (-), T. cruzi infection (-). * indicate statistically
significant differences.
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Figure 3. Effect of vitamin E and Se supplementation on IFN-y levels in spleen cell
cultures obtained from T. cr«z/-infected mice. The concentration of IFN-y released into
culture supernatants for each group of mice was measured on day 35 post-infection + 48
hour of culture (experiment 1) and on day 37 post-infection+ 48 hour of culture
(experiment 2) respectively. Data are presented as mean concentration plus standard
deviation. In experiment 1, mice were treated with vitamin E & Se for 72 days and were
15-16 weeks old when infected with T. cruzi. In experiment 2, mice were treated with
vitamin E and Se for 30 days and were 8 - 1 0 weeks old when infected with T. cruzi.
"+/+"= Group A: vitamin E & Se (+), T. cruzi infection (+). "+/-"= Group B: vitamin E
& Se (+), T. cruzi infection (-). "-/+"= Group C: vitamin E & Se (-), T. cruzi infection
(+). "-/-"= Group D: vitamin E & Se (-), T. cruzi infection (-).* indicate statistically
significant differences.
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Figure 4. Effect of vitamin E and Se supplementation on IL-10 levels in the serum
of T. cruzi -infected mice. The average concentration of IL-10 present in sera obtained
from mice in each group was measured on day 35 (experiment 1) and day 37 (experiment
2) post-infection, respectively. Data are presented as average concentration plus standard
deviation. Mice from experiment 1 were treated with vitamin E & Se for 72 days and
were 15-16 weeks old when infected with T. cruzi. Mice from experiment 2 were treated
with vitamin E and Se for 30 days and were 8-10 weeks old when infected with T. cruzi.
"+/+"= Group A: vitamin E & Se (+), T. cruzi infection (+). "+/-"= Group B: vitamin E
& Se (+), T. cruzi infection (-). "-/+'— Group C: vitamin E & Se (-), T. cruzi infection
(+). "-/-"= Group D: vitamin E & Se (-), T. cruzi infection (-).* indicate statistically
significant differences.

IL-10 Level in Serum
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Figure 5. Effect of vitamin E and Se supplementation on IL-10 levels in spleen
cultures obtained from T. cruzi- infected mice. The concentration of IL-10 released
into culture supernatants for each group of mice was measured on day 35 + 48 hours of
culture (experiment 1) and day 37 + 48 hours of culture (experiment 2) post-infection,
respectively. Data are presented as average concentration plus standard deviation. Mice
from experiment 1 were treated with vitamin E & Se for 72 days and were 15-16 weeks
old when infected with T. cruzi. Mice from experiment 2 were treated with vitamin E
and Se for 30 days and were 8-10 weeks old when infected with T. cruzi.

"+/+"=

Group A: vitamin E & Se (+), T. cruzi infection (+). "+/-"= Group B: vitamin E & Se
(+), T. cruzi infection (-). "-/+"= Group C: vitamin E & Se (-), T. cruzi infection (+). "/-"= Group D: vitamin E & Se (-), T. cruzi infection (-).* indicate statistically significant
differences.
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Figure 6. Effect of vitamin E supplementation on total RNA levels This assay was
performed with mice from experiment 2# on day 37 post-infection. Data are presented as
average RNA mass. "+/+"= Group A: vitamin E & Se (+), T. cruzi infection (+). "+/-"
= Group B: vitamin E & Se (+), T. cruzi infection (-). "-/+"= Group C: vitamin E & Se
(-), T. cruzi infection (+). "-/-"= Group D: vitamin E & Se (-), T. cruzi infection (-).*
indicate statistically significant differences.
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Figure 7. Effect of antioxidant supplementation on cytokine mRNA production in T.
cruzi-infected

mice. One representative autoradiograph is shown here. RNA isolated

from individual mice from each group in experiment 2 was analyzed by ribonuclease
protection assay (RPA). The bands represent different cytokine mRNAs. Lanes 2 - 8
represent RNA isolated from spleen tissue; Lanes 9 - 1 6 represent RNAs isolated from
heart tissue. "+/+" = Group A: vitamin E & Se (+), T. cruzi infection (+). "+/-" = Group
B: vitamin E & Se (+), T. cruzi infection (-). "-/+" = Group C: vitamin E & Se (-), T.
cruzi infection (+). " - / - ' - Group D: vitamin E & Se (-), T. cruzi infection (-). "1" and "2"
mean individual mice from the same group.
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Table 1. a. Average intensity of cytokine mRNA bands from spleen tissue of individual
mice in different treatment groups. "+/+" = Group A: vitamin E & Se (+), T. cruzi
infection (+). "+/-" = Group B: vitamin E & Se (+), T. cruzi infection (-). "-/+" = Group
C: vitamin E & Se (-), T. cruzi infection (+). "-/-" = Group D: vitamin E & Se (-), T. cruzi
infection (-).

b. Average intensity of cytokine mRNA bands from heart tissue of individual
mice in different treatment groups. "+/+" = Group A: vitamin E & Se (+), T. cruzi
infection (+). "+/-" = Group B: vitamin E & Se (+), T. cruzi infection (-). "-/+" = Group
C: vitamin E & Se (-), T. cruzi infection (+). "-/-" = Group D: vitamin E & Se (-), T.
cruzi infection (-).

Note: some band intensities indicated by a "0" were detectable, but after normalization
the values were not significantly different than zero.

Table 1
a. Average intensity of cytokine-bands from spleen mRNA

Group

IL-4

IL-5

IL-10

IL-13

IL-15

IL-9

IL-2

IL-6

IFN-r

A(s)

22

0

99

0

100

62

0

0

122

B(s)

0

0

16

0

76

27

0

0

63

C(s)

35

0

85

0

104

40

42

0

165

D(s)

0

0

0

0

85

0

0

0

76

b. Average intensity of cytokine-bands from heart mRNA

Group

IL-4

IL-5

IL-10

IL-13

IL-15

IL-9

IL-2

IL-6

IFN-r

A(h)

0

0

91

0

167

124

0

152

220

B(h)

0

0

0

0

153

44

0

87

100

C(h)

29

0

115

0

156

120

0

151

187

D(h)

0

0

0

0

147

0

0

0

113

DISCUSSION
In an effort to determine the mechanisms of protective antioxidant activity during
experimental Chagas' disease, the profiles of cytokines (especially of IFN-y and IL-10)
were evaluated at the protein and mRNA level in mice infected with T. cruzi after dietary
supplementation with vitamin E and Se. The results of the study show that vitamin E and
Se supplementation results in the enhancement of IFN-y and suppression in the
production of IL-10 compared with non-antioxidant treated mice. In this way, the
antioxidants function to shift the T-helper (Th) 1/Th2 cytokine balance towards a Thl
response. These changes were observed at both the protein level and the transcriptional
level and showed organ differences.
Cytokines play a fundamental role in the control of the immune response during
chronic human Chagas' disease as well as other infectious diseases (Reis et al., 1997).
Many experiments have been performed in an attempt to determine how the mammalian
host develops resistance to T. cruzi. The results of many studies that have focused on
cytokine regulation have shown that IL-12 is a key cytokine which powerfully induces
NK cells to produce high levels of IFN-y(Cardoni et al., 1999). IFN-y then activates
macrophages to produce NO, TNF-(3, and other factors which are capable of directly
killing the parasite (Gazzinelli et al., 1992; Vespa et al., 1994; Holscher et al., 1998).
During experimentally induced Chagas' disease, a Thl immune response characterized
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by IFN-y production and activation of macrophages plays a major role in resistance
during acute T. cruzi-infection

(Hoft et al., 1999). The balance of type 1 and type 2

cytokines then shifts in favor of IL-4 and IL-10 at 60 days or later following infection
(Talvani et al., 2000). Endogenous IL-10 can down regulate an over-productive proinflammatory cytokine response preventing TNF-a-mediated toxic shock (Holscher et al.,
2000). The balance between protective (e.g., IFN-y) and exacerbative cytokines (e.g., IL4 or IL-10) early in infection could be responsible for disease control and/or progression
(Meyer etal., 1998).
Cytokine changes following T. cruzi-infection
this study.

were confirmed by the results of

Compared to non-infected mice, IFN-y and IL-10 protein levels were

increased in serum (Figure 2 and Figure 4) and mRNA levels were increased in the heart
(Table la and Table lb) of infected mice. IL-4 and IL-6 mRNA levels also increased in
infected mice.
Compared with the non-antioxidant-treated but T. cruzi-infected

groups,

antioxidant-treated and T. crwzi-infected mice showed higher IFN-y levels, these
differences of IFN-y levels between two groups were statistically significant (p<0.05)
(Figure 2). In the groups of mice that were not infected by T. cruzi, very low IFN-y levels
were observed in both experiment 1# and 2#. Even though the mean IFN-y levels
appeared to be different, those differences between groups were not statistically
significant. In mice treated for a longer time (8~9weeks) with antioxidants, IFN-y levels
were higher than in mice treated for a shorter period of time (4~5weeks). The explanation
for this result is complicated because antioxidant, age, and other factors would all be
expected to beinvolved in this process. Based upon these results, antioxidant
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supplementation with vitamin E and Se leads to an enhancement in serum levels of IFN-y
in mice infected by T. cruzi.
In contrast, antioxidant supplementation resulted in a decrease in IL-10 levels in
non-infected mice (Figure 4). These differences were statistically significant (p<0.05).
These results also were consistent in both experiment #1 (mice treated 8-9 weeks) and
experiment 2# (mice treated 4-5 weeks). Although there were observed differences in IL10 levels in supplemented mice infected with T. cruzi, these differences were not
statistically significant (p>0.05).
IFN-y and IL-10 are major elements of the Thl and Th2 cytokine profiles,
respectively. Based upon the above results, it appears that antioxidant supplementation
shifts the cytokine response to Thl in two ways: in T. cruzi-infected

mice, the Thl/2

balance is shifted by increasing IFN-y levels, in non-infected mice, the Thl/2 balance is
changed by decreasing IL-10 levels. Although there appeared to be other effects of diet
on cytokine production, only the two changes mentioned above were statistically
significant. ELISA analysis of cytokine production at the protein level demonstrated that
IFN-y levels were higher in serum from T. cruzi-infected

mice supplemented with

vitamin E and Se as compared to non-antioxidant treated mice (Figure 2). These results
were confirmed by RPA analysis of cytokine mRNA levels within the heart (Table 1).
Generally, the optimum vitamin supplementation level is considered to be the
quantity that achieves the best growth rate, feed utilization, health (including immune
competency), and provides adequate body reserves (McDowell, 2000). Vitamin E and Se
both function as antioxidants. Both nutrients can impact the immune system and provide
protection against a variety of diseases in humans and other animals (Sheffy and Schultz,
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1979; Wise and Tomasso, 19931; Deshpande et al., 1996). When administered together,
they show a synergistic effect in depressing lipid peroxide formation (Douillet et al.,
1998). In addition, Vitamin E and Se show a positive synergistic effect on the immune
system when supplemented in quantities in excess of recommended levels (Scheffy and
Schultz, 1979). Combined supplementation of Se and vitamin E results in enhanced
macrophage function (Wise and Tomasso, 1993) and also enhanced antibody production,
cell proliferation, cytokine production, prostaglandin metabolism, and neutrophil function
(Desphande et al, 1996). In our laboratory, the combination of 400IU/kg vitamin E and
8ppm selenium was shown to provide the best overall protective effect in a murine model
of experimental Chagas' disease (Hou, 1997). Based upon the results of the present study,
the impact of these antioxidants on the production of immunoregulatory molecules such
as cytokines is an important mechanism for their immunostimulatory effects.
Molecular oxygen and reactive oxygen intermediates (ROI) are required for host
immunity to kill a variety of pathogens. Infection with T. cruzi stimulates tissues to
increase ROI production which results in reduced tissue antioxidant levels in the host.
Because the oxidant /antioxidant balance plays an important role in the regulation of
cytokines, high concentrations of vitamin E and Se can neutralize the effects of excess
reactive oxygen intermediates (Eugui et al., 1994). Depending upon the relative levels of
oxidants /antioxidants, Thl cytokines such as IFN-y may show increased production,
whereas Th2 cytokines such as IL-10 and IL-4 levels may be decreased. During T h l dominant immune responses, more active oxygen intermediates are produced and antimicrobial activity is enhanced. This response is important in the control and spread of the
pathogen (Han and Meydani, 2000). Under these circumstances the antioxidants vitamin

43
E and Se may function to inhibit excessive inflammatory reactions. Therefore, the host
immune response produces a protective function with limited pathological effects.
The work of Vilcek (1998) provided significant insight into the function of signal
transduction pathways in the regulation of cytokine production. Redox status can regulate
at least two transcription factors, nuclear factor ( N F ) - K B and activator protein ( A P ) - L .
Many cytokine genes have been shown to have N F - K B and AP-1-binding sites in their
promoter and enhancer regions. DNA binding and transactivation activities in
transcriptional activator-dependent and cell type-dependent events can be up- or downregulated by the relative levels of reduction /oxidation products (Sun et al, 1996).
Vitamin E can inhibit N F - K B activation and this regulation has "been shown to be cell
type-specific (Sun and Oberley, 1996).
A second possible mechanism is the regulation of cytokine production by
prostaglandin E2 ( P G E 2 ) . P G E 2 can affect Thl/Th2 cytokine secretion through IL-12
(Gately et al., 1998), and can up-regulate IL-6 production in macrophages (Thivierge and
Rola-Pleszczynski, 1994). P G E 2 also has been shown to inhibit the early stages of T cell
activation by decreasing IL-2 levels and down-regulating IL-2 receptor expression
(Vercammen and Ceuppens, 1987). Vitamin E has been shown to decrease the production
PGE2

in old mice (Wu et al., 1998). Therefore, during vitamin E supplementation, IL-12

and IL-6 levels decrease whereas IL-2 levels increase and result in T cell activation.

In addition, at the cellular level vitamin E can help to protect the integrity of the
cell membrane against ROI attack (Dutta-Roy et al., 1994; Deshpande et al., 1996). A
stable cell membrane is necessary for normal cell function and as well as defense against
invading pathogens.
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The simultaneous presence of antigenic and antibody stimulation in the host
during the chronic phase of Chagas' disease could explain the existence of both
inflammatory and anti-inflammatory cellular reactivity detected in most patients (Dutra et
al., 1997). The heart continues to be a major site of infection for the parasite, even after
the acute phase of Chagas' disease (Tarleton & Zhang. 1999). Therefore, it is of interest
to compare levels of inflammation between heart and spleen tissues in the antioxidantsupplemented mice and non-supplemented mice during experimental Chagas' disease.
One of the hallmarks of

T. cruzi-infection is that the parasite demonstrates a

preference for particular host organs or tissues. Furthermore, the parasite infection
persists within tissues during the chronic stage of infection, which promotes high levels
of oxidative processes, and causes severe destruction to the tissue. Trypanosoma

cruzi

stimulates a Thl response within tissues which promotes the synthesis of increased levels
of oxidative intermediates (Bussing et al., 1999). The results are chronic inflammation
and pathologic damage to the tissue. As the level of oxygen intermediates varies in
different organs (depending on the level of infection), antioxidants may affect the organs
in different ways when the host is supplemented. The reduced numbers of blood-form
trypomastigotes observed in mice in the present study were correlated with lower levels
of inflammation, tissue parasitism, and tissue destruction. There is much evidence to
suggest that CD8+ lymphocytes are the main effecter cells responsible for cardiac tissue
destruction during T. cruzi infection (Brener & Gazzinelli, 1997). Nitric oxide generated
from cardiac inducible nitric oxide synthase ( N O S 2 ) may be involved the pathogenesis of
murine chagasic heart disease (Huang et al., 1999). In addition to mechanical damage by
T. cruzi, substantial pro-inflammatory cytokine production within the myocardium is also
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likely to participate in the pathophysiology of acute Chagasic cardiomyopathy
(Chandrasekar et al., 1998). The infection-associated expression of cytokines and NOS2
in the heart is clearly correlated with the severity of myocarditis (Huang et al, 1999).
Chronic inflammation in Chagasic hearts is highly active and associated with a stable
immunological pattern extending from the early acute stage of the infection through the
late chronic stage (Zhang and Tarleton, 1999).
The results of the present study suggest that cytokine expression differs in
different organs. The RPA analysis of the expression of cardiac cytokines demonstrated a
significant increase in IL-6 and IL-10. IL-10 levels in heart tissue were higher than levels
observed in the spleen. Similarly, IL-6 levels were elevated in the heart whereas the
spleen showed no detectible levels of IL-6. IL-6 is secreted by many different kinds of
cells and plays an important role in the regulation of immune and acute-phase responses.
IL-6 is important in T cell activation, growth, and differentiation as well as B cell
differentiation (Goldsby et al., 2000). IL-6 also is involved in the pathogenesis of many
autoimmune disorders and in chronic proliferative disease (Hirano, 1994). In contrast to
the results observed for IL-6, IL-2 and IL-4 were expressed at slightly higher levels in
spleen cells than in heart tissue. IL-2 is a Thl cytokine, which is essential in the immune
response and required for the rapid proliferation of T cells. However IL-2 is inhibited in
chronic Chagas' disease (Robert & Janovy, 1996). IL-4 is regarded as a Th2 cytokine and
can stimulate B cells to make IgGl and IgE. In a study by Zhang & Tarleton (1996), IL-6
was consistently observed in heart lesions appearing during the acute infection and
persisting throughout the chronic stage of infection. In contrast, cells producing IL-2, IL4, and IL-5 were not observed in the hearts of mice at any point during the infection. The
authors also reported that the patterns of cytokine production in the heart were very
different than profiles observed in lymphoid organs. Based upon the results of the their
study, Zhang and Tarleton (1996) concluded that both inflammatory and anti-
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inflammatory cytokines determine the pattern of the cellular response and the severity of
disease in T. cruzi infection. Powell (1998) also showed that the differences in the
profiles of cytokine mRNA may be related to the differential degree of cardiac pathology
that develops in different strains of mice upon infection with T. cruzi. The results of the
present study confirm that cytokine levels such as IL-6 and IL-10 are elevated in the heart
as compared to the levels expressed in the spleen, indicating that Th2 responses may
dominate and likely contribute to the pathology of Chagasic cardiomyopathy.
There are substantial data that support a possible role for autoimmunity in the
pathogenesis of Chagas' disease, in which anti-parasite immune responses have crossreactivity with self-molecules in T. cruzi-infected

hosts (Kalil and Cunha-Neto, 1996).

However, recent studies both in mice and humans indicate a positive association between
tissue parasitism, inflammation, and severity of pathology induced by T. cruzi (Zhang &
Tarleton, 1999). Strong evidence has been provided that parasite persistence within
tissues is a primary cause of chronic Chagas' disease (Zhang & Tarleton, 1999). Many
lines of evidences have shown that the persistence of T. cruzi at specific sites in the
infected host results in chronic inflammatory reactivity and accounts for pathogenesis in
chronic T. cruzi infections. It has become increasingly apparent that chronic Chagasic
cardiac disease (CCCD) should be investigated and treated as a parasitic infection and not
as an autoimmune disease (Tarleton, 2001).

In conclusion, the results of the present study have confirmed that antioxidants
have a beneficial effect during experimental Chagas' disease. Furthermore, antioxidant
supplementation with vitamin E and Se can tip the Thl/Th2 cytokine balance to a Thlpredominant response. This shift to a Thl response was shown to be affected by infection
status. The observed changes in cytokine synthesis showed organ differences between the
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heart and spleen. Alterations in cytokine production within the heart may contribute to
Chagas' cardiac pathology.

Much remains to be learned as regards how T cells may contribute to immune
resistance as well as to the pathogenesis of T. cruzi-infection

and chronic Chagasic

cardiac disease. Further studies are needed to fully define the impact of antioxidants on
the dynamics of cytokine regulation and the balance between protective immunity and
immunopathology during experimental and human Chagas' disease.
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